VCWA
ELV icon

Vanguard Capital Wealth Advisors’s Elevance Health ELV Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,106
Closed -$1.14M – 133
2024
Q2 		$1.14M Buy
2,106
+6
+0.3% +$3.17K 0.77% 25
2024
Q1 		$1.09M Buy
2,100
+7
+0.3% +$3.48K 0.77% 28
2023
Q4 		$987K Buy
2,093
+6
+0.3% +$2.77K 0.8% 21
2023
Q3 		$909K Buy
2,087
+7
+0.3% +$3.17K 0.84% 23
2023
Q2 		$924K Buy
2,080
+7
+0.3% +$3.23K 0.84% 24
2023
Q1 		$953K Buy
2,073
+7
+0.3% +$3.33K 0.95% 21
2022
Q4 		$1.06M Buy
2,066
+5
+0.2% +$2.54K 1.23% 17
2022
Q3 		$936K Buy
2,061
+6
+0.3% +$2.87K 1.14% 17
2022
Q2 		$991K Buy
2,055
+5
+0.2% +$2.47K 1.12% 21
2022
Q1 		$1.01M Buy
2,050
+6
+0.3% +$2.74K 0.72% 36
2021
Q4 		$947K Buy
2,044
+5
+0.2% +$2.1K 0.68% 40
2021
Q3 		$760 Buy
2,039
+6
+0.3% +$2.28K 0.51% 47
2021
Q2 		$776K Buy
+2,033
New +$777K 0.59% 44
2021
Q1 		– Sell
-2,020
Closed -$634K – 140
2020
Q4 		$634K Buy
+2,020
New +$620K 0.58% 42
2020
Q2 		$530K Buy
+2,016
New +$538K 0.62% 43
2019
Q4 		$604K Hold
2,000
– – 0.63% 42
2019
Q3 		$570K Buy
+2,000
New +$548K 0.66% 46
2019
Q2 		– Sell
-2,000
Closed -$573K – 124
2019
Q1 		$573K Hold
2,000
– – 0.72% 43
2018
Q4 		$525K Hold
2,000
– – 0.78% 42
2018
Q3 		$548K Hold
2,000
– – 0.63% 51
2018
Q2 		$476K Hold
2,000
– – 0.63% 58
2018
Q1 		$443K Hold
2,000
– – 0.58% 56
2017
Q4 		$450K Buy
+2,000
New +$426K 0.56% 56

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Capital Wealth Advisors's ELV Position: Q3 2024 in Review

Vanguard Capital Wealth Advisors sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2,106 shares — an estimated $1.14M sold.

Vanguard Capital Wealth Advisors first reported a position in ELV in Q4 2017 and held it in 23 quarters. The position peaked at $1.14M in Q2 2024. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Vanguard Capital Wealth Advisors reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 2,106 Elevance Health shares in Q3 2024, an estimated $1.14M.
  • Vanguard Capital Wealth Advisors first reported a position in Elevance Health in Q4 2017 and held it in 23 quarters.
  • Vanguard Capital Wealth Advisors's Elevance Health position peaked at $1.14M in Q2 2024.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.